Stock listing

Santen Pharmaceutical Co., Ltd.

Selected listing: 864318 · LSX · EUR · DE

Santen Pharmaceutical Co., Ltd. (LS Exchange: 864318), Health Technology. Latest release Sep 30, 2026: Notice on the Completion of Disposal of Treasury Shares…

864318:LSXEURDEUpdated September 26, 2026

Ticker: LS Exchange: 864318
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

Latest news from Santen Pharmaceutical Co., Ltd.

Notice on the Completion of Disposal of Treasury Shares for the Post-delivery Type Performance-Linked Stock Remuneration Plan

September 30, 2026

Santen Pharmaceutical : New Drug Application Filing Accepted for Review in China for STN1012700 (Atropine Sulfate Ophthalmic Solution 0.025%), an Ophthalmic Solution to Slow the Progression of Myopia

September 14, 2026

Notice on the Disposal of Treasury Shares for the Post-delivery Type Performance-Linked Stock Remuneration Plan

September 3, 2026

Summary of Consolidated Financial Results for the Three Months Ended June 30, 2026 (IFRS)

August 6, 2026

Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan

June 19, 2026

All Santen Pharmaceutical Co., Ltd. news →

Research Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd. company profile

View the public company page for Santen Pharmaceutical Co., Ltd. on 6ix.

Santen Pharmaceutical Co., Ltd. news

Read company news and market updates connected to Santen Pharmaceutical Co., Ltd..

Santen Pharmaceutical Co., Ltd. investor events

Find investor webinars, events, and replay context for Santen Pharmaceutical Co., Ltd..